NCT06185088

Brief Summary

This study will utilize approved devices in an off-label manner to create forces required to induce intestinal lengthening. Radial and longitudinal forces are both required, and two devices will be used to create forces in order to test tolerability of said forces. This is to provide evidence that humans could tolerate the forces produced by a proposed commercially built device. This study will test the hypothesis that radial and longitudinal forces necessary to produce enterogenesis will cause low levels of discomfort in healthy adults. Approved devices will be utilized in an off-label manner to reproduce forces similar to our novel medical device which is designed to treat short bowel syndrome (SBS). This trial will not be testing a treatment for SBS, and individuals with SBS are ineligible for recruitment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 29, 2023

Completed
9 months until next milestone

Results Posted

Study results publicly available

October 3, 2024

Completed
Last Updated

October 3, 2024

Status Verified

September 1, 2024

Enrollment Period

3 months

First QC Date

December 14, 2023

Results QC Date

July 30, 2024

Last Update Submit

September 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Discomfort as Assessed by Visual Analog Scale (VAS) for Radial Stretch

    Participant discomfort will be assessed using VAS during radial stretch. The VAS is a scale ranging from 0 (no pain) to 10 (maximum pain).

    1-2 Minutes

Secondary Outcomes (1)

  • Discomfort as Assessed by Visual Analog Scale for Longitudinal Stretch

    Approximately 1 minute

Study Arms (1)

Participants with Ostomies

OTHER

Patients who have ostomies, and who are already undergoing a minor procedure for routine health screening or other health matters as standard of care.

Device: Coda® Balloon CathetersDevice: Double Balloon Endoscope (DBE)

Interventions

A balloon device that will be introduced into participants' intestine over a guide wire to test the radial stretch of the small bowel.

Participants with Ostomies

A balloon device that will be introduced retrograde through the ileostomy and the inter-balloon distance will be increased causing stretch on the intestine to test longitudinal stretch. The DBE will only be used if a participant tolerated the Coda® Balloon Catheter intervention.

Participants with Ostomies

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Existing Ileostomy older than 6 weeks Undergoing any existing procedure in endoscopy suite or operating room.

You may not qualify if:

  • Inflammatory bowel disease of small bowel Pregnant Short bowel syndrome Bleeding disorder Chronic pain disorder Individuals taking chronic pain medications including prescriptions, cannabinoids or over the counter.
  • Individuals taking pain medications at the time of the procedure Cognitive Impairment to the extent that the questionnaire cannot be completed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michigan Medicine

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Short Bowel Syndrome

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Meghan Arnold
Organization
University of Michigan

Study Officials

  • Meghan A Arnold, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

December 14, 2023

First Posted

December 29, 2023

Study Start

March 6, 2023

Primary Completion

June 6, 2023

Study Completion

June 6, 2023

Last Updated

October 3, 2024

Results First Posted

October 3, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations